Pacific Biosciences makes DNA sequencing systems, reagents and services for researchers, clinical labs and drug developers. It last closed at $1.82 on Nov 17, down 1.09% on the day. PACB reports earnings on Tue, Feb 9, 2027. The average 12-month price target from 3 analysts is $2.57 (+41.0% from the last close), with a high of $3.00 and a low of $2.00. Analyst consensus is Hold, based on the latest ratings from 3 firms (0 buy, 2 hold, 1 sell). Over the past 90 days StreetAlpha recorded 3 whale options trades in PACB, 33% of them bullish and 67% bearish. In the past 30 days there were 6 dark pool prints totaling $841K, the largest $169K.
Each firm's latest rating on PACB in the past 90 days
Average 12-month target
$2.57
▲ 41.0% upside
Based on 3 analysts who set a price target on PACB in the past 90 days. The average target is $2.57, with a high of $3.00 and a low of $2.00, compared with the last close of $1.82.
Highest target$3.00
Average target$2.57
Lowest target$2.00
Latest rating changes
UBSTarget raised
Nov 9Hold$1.35 → $2.70
BarclaysTarget raised
Nov 5Sell$1.50 → $2
Piper SandlerReiterated
Nov 5Hold$3
UBSAssumed coverage
Sep 9Hold$1.35
BarclaysDowngrade
Mar 6Sell$1.50
Date
Firm
Action
Rating
Price target
Nov 9
UBS
Target raised
Hold
$1.35 → $2.70
Nov 5
Barclays
Target raised
Sell
$1.50 → $2
Nov 5
Piper Sandler
Reiterated
Hold
$3
Sep 9
UBS
Assumed coverage
Hold
$1.35
Mar 6
Barclays
Downgrade
Sell
$1.50
Loading…
Technical Analysis
PACB · as of the Nov 17 close · updated after every close
Pullback inside a longer uptrend
The stock is 25% below its 20 day and 11% below its 50 day average. It is 12% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 40). The nearest support is the Pivot at $1.81, and the nearest resistance the swing high (Jul 2) at $1.84.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityHigh, 14.2%/day
Key levels
$3.4452 week high+89.0%
$2.2820 day average+25.3%
$2.0250 day average+11.0%
$1.89Pivot R1+3.8%
$1.84Swing high (Jul 2)+1.1%
$1.82Last close
$1.81Pivot−0.5%
$1.74Pivot S1−4.4%
$1.71100 day average−6.0%
$1.70Swing low (Oct 16)−6.6%
$1.60200 day average−12.1%
$1.0752 week low−41.2%
Indicators
RSI (14)
39.82
Weak, oversold below 30
Neutral
MACD
-0.04
Below its signal line
Bearish
Stochastic
7.7
Near the bottom of its range
Oversold
ADX (14)
25.6
Trending down
Williams %R
-92.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-129.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.4%
Change over 10 sessions
Bearish
ATR (14)
$0.26
Typical daily range, 14.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
Rising
Short trendBullish
Long trendNot enough history
MomentumImproving
StretchNormal
VolatilityHigh, 24.0%/day
Key levels
$3.4452 week high+89.0%
$2.2820 day average+25.3%
$2.0250 day average+11.0%
$1.89Pivot R1+3.8%
$1.84Swing high (Jul 2)+1.1%
$1.82Last close
$1.81Pivot−0.5%
$1.74Pivot S1−4.4%
$1.71100 day average−6.0%
$1.70Swing low (Oct 16)−6.6%
$1.60200 day average−12.1%
$1.0752 week low−41.2%
Indicators
RSI (14)
50.94
Middle of its range
Neutral
MACD
0.16
Above its signal line
Bullish
Stochastic
39.2
Middle of its range
Neutral
ADX (14)
31.4
Trending up
Williams %R
-69.8
Oversold below −80, overbought above −20
Neutral
CCI (20)
18.0
Oversold below −100, overbought above 100
Neutral
Rate of change
+40.0%
Change over 10 sessions
Bullish
ATR (14)
$0.44
Typical daily range, 24.0% of price
MA 10Below
MA 20Above
MA 50Above
MA 100Above
MA 200–
What happened before, for PACB
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PACB did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Whale flow leans bearish1 bullish and 2 bearish whale options trades in the last 90 days. See Whale Flow
November seasonalityHow PACB usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How PACB has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2010.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PACB is in one of them and how their past PACB trades turned out.
Pacific Biosciences is a life science technology company based in Menlo Park, California, that designs and makes DNA sequencing systems. Its offerings include sequencing instruments, nanofluidic chips, reagents, software and sequencing services that read long stretches of DNA with high accuracy. Its customers include academic and government research institutions, clinical and testing laboratories, hospitals, public health labs, pharmaceutical companies, contract research organizations and agricultural companies.